Live feed
Filing
SC 13D
SC 13D0001104659-20-006330·Avista Capital Partners III GP, L.P.
Schedule 13D ownership disclosure
RVL PHARMACEUTICALS PLC
Security class unavailable · CUSIP: G6S41R101
Event date: 2020-01-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,969,921
- Percent of class
- 10.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-006330
- Form type
- SC 13D
- Filer
- Avista Capital Partners III GP, L.P.
- CIK
- CIK 1705722
- Filed
- Jan 23, 2020
- Reporting period
- Jan 13, 2020
- Description
- Schedule 13D beneficial ownership